Readout Newsletter: Kailera, Zepbound, Certara, BioLabs

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Good morning. We have a short and sweet newsletter today. And if you are in any areas hit by the flash foods, I hope you’re staying safe.

A lab pioneer fears U.S. industry is losing its edge

Johannes Fruehauf, founder of laboratory real estate companies LabCentral and BioLabs, is increasingly looking to Europe — and even Saudi Arabia — as U.S. policies cloud the future of biotech stateside.

STAT+ Exclusive Story

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.

Already have an account? Log in

View All Plans

To read the rest of this story subscribe to STAT+.

Subscribe

Continue Reading